Forxiga
5 customer reviewsForxiga is an oral tablet containing dapagliflozin, an SGLT2 inhibitor. It is for adults with type 2 diabetes and selected patients with chronic heart failure or chronic kidney disease. It lowers blood sugar by helping the kidneys remove excess glucose in urine.
What is it?
Forxiga is a once-daily tablet medicine that contains Dapagliflozin. Dapagliflozin is an SGLT2 inhibitor, a class used to improve blood sugar control in type 2 diabetes.
Beyond glucose control, many clinicians also use Forxiga as part of guideline-based care in selected adults with chronic heart failure and chronic kidney disease, because SGLT2 inhibitors can support heart and kidney outcomes in the right patient. [2]
Composition
Active ingredient: dapagliflozin (as dapagliflozin propanediol monohydrate). Forxiga is supplied as film-coated oral tablets, commonly in strengths of 5 mg and 10 mg dapagliflozin, with standard tablet excipients forming the core and coating.
How to use?
Forxiga is taken by mouth, with or without food. The standard adult dose used for many indications is 10 mg once daily, taken at about the same time each day.
Practical administration points that matter in real life:
- Swallow the tablet whole with water.
- If you miss a dose, take it when you remember on the same day. If it is close to the next dose, skip the missed dose and continue as normal.
- If you also use insulin or a sulfonylurea, your prescriber may reduce that dose to lower the chance of hypoglycaemia.
Do not double doses. Routine matters.
How does it work?
- Dose: 10 mg
- Frequency: 1 time/day
- Timing: take at the same time each day; with or without food
- Route: oral (swallow the tablet with water)
- Duration: long-term daily treatment as prescribed by a clinician
Indications
Forxiga is a medicine used to manage type 2 diabetes by helping to lower blood sugar levels. It is for adults who need better glucose control, and it is also used in chronic heart failure and chronic kidney disease in suitable patients.
Comparison
Forxiga can be used alone or combined with other diabetes medicines, and combinations are common in practice. The key interaction theme is additive glucose-lowering or additive fluid loss.
Interactions clinicians actively plan for
- Insulin and sulfonylurea: higher hypoglycaemia risk, so doses may need review.
- Diuretics (water tablets): higher risk of dizziness, dehydration, and low blood pressure.
- Blood pressure medicines: monitoring may be needed early, since Forxiga can modestly lower blood pressure.
For alternatives, the choice depends on your goals: glucose lowering, weight, kidney protection, heart protection, and tolerance. Here is a simple comparison patients usually understand quickly:
| Option | How it works | Common issues |
|---|---|---|
| Forxiga (dapagliflozin) | SGLT2 inhibitor; increases glucose excretion in urine | Thrush/UTIs, thirst, dehydration; rare DKA risk |
| Metformin | Reduces liver glucose output; improves insulin sensitivity | Stomach upset; not suitable in some kidney/lactic acidosis risk settings |
| Sitagliptin | DPP-4 inhibitor; increases incretin effect | Generally well tolerated; modest glucose effect for many people |
When a sulfonylurea is part of the plan, it can lower glucose strongly, yet it carries more hypoglycaemia risk than Forxiga for many patients. This trade-off is one reason prescribers often move toward SGLT2 inhibitors or other modern agents when appropriate. [3]
Contraindications
- Hypersensitivity to Dapagliflozin or any component of Forxiga
- Type 1 diabetes mellitus
- Severe renal impairment (creatinine clearance below 25 mL/min) or end-stage renal failure
- Pregnancy
- Breastfeeding
Not recommended for
Forxiga may not be suitable if you:
- Have ever had an allergic reaction to dapagliflozin or ingredients in the tablet
- Have type 1 diabetes, where this type of medicine can raise the risk of diabetic ketoacidosis
- Have very poor kidney function or kidney failure
- Are pregnant or breastfeeding
Side effects
Most side effects relate to how Forxiga increases glucose in urine and slightly increases fluid loss. Many people tolerate it well, yet the same mechanism can cause predictable issues that are easier to manage when you know what to look for.
Common side effects
- Genital yeast infections (thrush), more likely if you have had them before
- Urinary tract infection symptoms (burning, urgency, lower abdominal discomfort)
- Increased urination and thirst
- Dizziness or low blood pressure, more likely in hot weather or if you also take diuretics
Less common but serious side effects needing urgent medical assessment
- Diabetic ketoacidosis (DKA) can happen even when glucose is not very high; risk rises with fasting, dehydration, heavy alcohol intake, or acute illness
- Severe dehydration or fainting
- Severe allergic reaction
One nuance I see often: symptoms of a genital yeast infection can start as simple itching and irritation, not always obvious discharge. Treating early tends to reduce downtime and recurrence.
Common mistakes
A lot of Forxiga “failures” are avoidable and come down to small habits.
- Starting when already dehydrated: beginning therapy during a stomach bug or after prolonged fasting can worsen dizziness and raise DKA risk.
- Ignoring early genital symptoms: waiting a week with itching often turns a small thrush episode into a bigger interruption.
- Not adjusting insulin or sulfonylurea: some people keep the same dose and then get repeated hypos, especially in the first month.
- Assuming any nausea means food poisoning: nausea, abdominal pain, and deep fatigue can be DKA warning signs, even without very high glucose.
- Stopping abruptly after frequent urination: the early increase in urination often settles; stopping and restarting repeatedly can make side effects feel worse.
Doctor opinions
In clinical practice, doctors often choose Forxiga when type 2 diabetes overlaps with heart failure or chronic kidney disease, because a single medicine can support several outcomes at once. The trade-off is that the benefits come with “mechanism-based” side effects: more glucose in urine means more genital yeast infections and a higher chance of urinary symptoms in susceptible people.
Frequently asked questions
Forxiga is manufactured by AstraZeneca. In practice, the brand name matters for identification, but the therapeutic effect is driven by Dapagliflozin as the active ingredient. Regulatory evaluation of dapagliflozin’s benefits and risks is covered in public assessment documents. [4]
Forxiga is not recommended for type 1 diabetes because SGLT2 inhibitors increase the risk of diabetic ketoacidosis in this group. People with type 1 diabetes can develop DKA with less dramatic glucose elevation than expected, which can delay recognition. [5]
Glucose-lowering begins soon after regular daily dosing starts, since the kidney transporter is inhibited each day the medicine is taken. Many patients first notice a pattern of lower readings within the first 1–2 weeks, while HbA1c improvements are assessed over a longer period.
On its own, Forxiga has a low tendency to cause hypoglycaemia because it does not directly push insulin release. The risk rises when it is combined with insulin or a sulfonylurea, because those medicines can drive glucose too low. If hypos start after adding Forxiga, dose adjustment of the other agent is a common fix.
Forxiga increases glucose excretion in urine, and glucose can promote yeast growth around the genital area in susceptible people. UTIs can also occur, though many urinary symptoms are mild and treatable when addressed early. Recurrent infections deserve a prescriber review to weigh benefits against tolerance.
Forxiga can be used in chronic kidney disease in selected patients, yet kidney function also sets limits for safe use. Severe renal impairment (creatinine clearance below 25 mL/min) is a contraindication in the product information you should be prescribed against. Kidney function monitoring is part of safe long-term therapy planning.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Forxiga — Comparison with alternatives
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2026). Forxiga (dapagliflozin): Summary of Product Characteristics (SmPC). ↑
- NAFDAC (National Agency for Food and Drug Administration and Control) (2026). Pharmacovigilance and regulated medicines guidance for Nigeria. ↑
- World Health Organization (WHO) (2026). WHO guideline: Pharmacological treatment of diabetes and cardiovascular risk management. ↑
- European Medicines Agency (EMA) (2026). SGLT2 inhibitors: risk minimisation guidance and safety information for dapagliflozin. ↑
- World Health Organization (WHO) (2026). Diabetic ketoacidosis: clinical guidance for recognition and prevention in diabetes care. ↑